Jan 21, 2020 / 10:15PM GMT
Operator
Thank you for standing by, and welcome to the ImpediMed Limited quarterly results investor conference call. (Operator Instructions)
I would now like to hand the conference over to Mr. Richard Carreon, Managing Director and CEO. Please go ahead.
Richard Carreon - ImpediMed Limited - MD, CEO, President & Executive Director
Thank you, Rachel. Welcome, and thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending December 31, 2019.
Before I begin, we at ImpediMed would like to convey our deepest sympathies to all of Australia that you continue to battle the destructive fires that have ravaged your beautiful country. The loss of life and the sheer magnitude of the damage is beyond comprehension. Our heartfelt thoughts and prayers go out to you all.
On today's call, I'll be referencing the 4C we lodged earlier this morning, Australian time. Joining me is Cathy Kingsford, our Senior Vice President of Clinical and Regulatory Affairs; and Tim Cruickshank, our Vice President of
Q2 2020 ImpediMed Ltd Earnings Call Transcript
Jan 22, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers